Preparation and in vitro evaluation of surface-modified poly (lactide-co-glycolide) microparticles as biodegradable drug carriers for pulmonary peptide and protein delivery

References

• Alpar HO, Somavarapu S, Atuah KN, Bramwell VW. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv Drug Deliv Rev, 2005;57:411–30
   PubMed Web of Science ®Google Scholar
• Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm, 2009;71:505–18
   PubMed Web of Science ®Google Scholar
• Aubert-Pouessel A, Venier-Julienne M-C, Clavreul A, Sergent M, Jollivet C, Montero-Menei CN, Garcion E, Bibby DC, Menei P, Benoit J-P. In vitro study of GDNF release from biodegradable PLGA microspheres. J Control Release, 2004;95:463–75
   PubMed Web of Science ®Google Scholar
• Bansil R, Stanley E, LaMont JT. Mucin biophysics. Ann Rev Physiol, 1995;57:635–57
   PubMed Web of Science ®Google Scholar
• Bittner B, Morlock M, Koll H, Winter G, Kissel T. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: Influence of the encapsulation technique and polymer purity on microsphere characteristics. Eur J Pharm Biopharm, 1998;45(3):295–305
   PubMed Web of Science ®Google Scholar
• Bravo-Osuna I, Vauthier C, Farabollini A, Palmieri GF, Ponchel G. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials, 2007;28:2233–43
   PubMed Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. Int J Pharm, 2008;346(1–2):151–9
   PubMed Web of Science ®Google Scholar
• Chen H, Yang W, Chen H, Liu L, Gao F, Yang X, Jiang Q, Zhang Q, Wang Y. Surface modification of mitoxantrone-loaded PLGA nanospheres with chitosan. Colloids Surf B: Biointerfaces, 2009;73:212–18
   PubMed Web of Science ®Google Scholar
• Chronopoulou L, Massimi M, Giardi MF, Cametti C, Devirgiliis LC, Dentini M, Palocci C. Chitosan-coated PLGA nanoparticles: A sustained drug release strategy for cell cultures. Colloids Surf B: Biointerfaces, 2013;103:310–17
   PubMed Web of Science ®Google Scholar
• Dash M, Chiellini F, Ottenbrite R, Chiellini E. Chitosan -- a versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci, 2011;36:981–1014
   Web of Science ®Google Scholar
• Den Otter W, Jacobs JJL, Battermann JJ, Hordijk GJ, Krastev Z, Moiseeva EV, Stewart RJE, Ziekman PGPM, Koten JW. Local therapy of cancer with free IL-2. Cancer Immunol Immunother, 2008;57:931–50
   PubMed Web of Science ®Google Scholar
• Devrim B, Bozkır A. Preparation and evaluation of double-walled microparticles prepared with a modified water-in-oil-in-oil-in-water (w1/o/o/w3) method. J Microencapsul, 2013;30(8):741--54
   Google Scholar
• Devrim B, Bozkır A, Canefe K. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations. Drug Dev Ind Pharm, 2011a;37(11):1376–86
   PubMed Web of Science ®Google Scholar
• Devrim B, Bozkır A, Canefe K. Preparation and evaluation of PLGA microparticles as carrier for the pulmonary delivery of rhIL-2: I. Effects of some formulation parameters on microparticle characteristics. J Microencapsul, 2011b;28(6):582–94
   PubMed Web of Science ®Google Scholar
• Gonda I. The ascent of pulmonary drug delivery. J Pharm Sci, 2000;89:940–5
   PubMed Web of Science ®Google Scholar
• He P, Davis SS, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm, 1998;166:75–88
   Web of Science ®Google Scholar
• Hejazi R, Amiji M. Chitosan-based gastrointestinal delivery systems. J Control Release, 2003;89:151–65
   PubMed Web of Science ®Google Scholar
• Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res, 1998;15:1326–31
   PubMed Web of Science ®Google Scholar
• Jeong YI, Shim YH, Kim C, Lim GT, Choi KC, Yoon C. Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(dl-lactide-co-glycolide). J Microencapsul, 2005;22:593–601
   PubMed Web of Science ®Google Scholar
• Johansen P, Tamber H, Merkle HP, Gander B. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs. Eur J Pharm Biopharm, 1999;47:193–201
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Yamamoto H, Takeuchi H, Kuno Y. Mucoadhesive dl-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm Dev Technol, 2000;5:77–85
   PubMed Web of Science ®Google Scholar
• Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev, 2010;62:3–11
   PubMed Web of Science ®Google Scholar
• Kim TH, Lee H, Park TG. Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres. Biomaterials, 2002;23:2311–17
   PubMed Web of Science ®Google Scholar
• Lee D-W, Shirley SA, Lockey RF, Mohapatra SS. Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respir Res, 2006;7:1–10
   PubMed Web of Science ®Google Scholar
• Lee ES, Park K-H, Park IS, Na K. Glycol chitosan as a stabilizer for protein encapsulated into poly(lactide-co-glycolide) microparticle. Int J Pharm, 2007;338:310–16
   PubMed Web of Science ®Google Scholar
• Lipworth BJ. Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol, 1996;42:697–706
   PubMed Web of Science ®Google Scholar
• Madsen F, Eberth K, Smart JD. A rheological examination of the mucoadhesive/mucus interaction: The effect of mucoadhesive type and concentration. J Control Release, 1998;50:167–78
   PubMed Web of Science ®Google Scholar
• Malaekeh-Nikouei B, Sajadi Tabassi SA, Jaafari MR. Preparation, characterization, and mucoadhesive properties of chitosan-coated microspheres encapsulated with cyclosporine A. Drug Dev Ind Pharm, 2008;34:492–8
   PubMed Web of Science ®Google Scholar
• Manca M-L, Mourtas S, Dracopoulos V, Fadda AM, Antimisiaris SG. PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization. Colloids Surf B: Biointerfaces, 2008;62:220–31
   PubMed Web of Science ®Google Scholar
• Meng FT, Ma GH, Qiu W, Su ZG. W/O/W double emulsion technique using ethyl acetate as organic solvent: Effects of its diffusion rate on the characteristics of microparticles. J Control Release, 2003;91:407–16
   PubMed Web of Science ®Google Scholar
• Modi J, Joshi G, Sawant K. Chitosan based mucoadhesive nanoparticles of ketoconazole for bioavailability enhancement: Formulation, optimization, in vitro and ex vivo evaluation. Drug Dev Ind Pharm, 2013;39(4):540–7
   PubMed Web of Science ®Google Scholar
• Peppas NA, Huang Y. Nanoscale technology of mucoadhesive interactions. Adv Drug Deliv Rev, 2004;56:1675–87
   PubMed Web of Science ®Google Scholar
• Sharma R, Saxena D, Dwivedi AK, Misra A. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Pharm Res, 2001;18:1405–10
   PubMed Web of Science ®Google Scholar
• Singla AK, Chawla M, Singh A. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: A review. Drug Dev Ind Pharm, 2000; 26(9):913–24
   PubMed Web of Science ®Google Scholar
• Smith DJ, King WF, Barnes LA, Trantolo D, Wise DL, Taubman MA. Facilitated intranasal induction of mucosal and systemic immunity to mutans streptococcal glucosyltransferase peptide vaccines. Infect Immun, 2001;69:4767–73
   PubMed Web of Science ®Google Scholar
• Smyth HDC, Hickey AJ. Carriers in drug powder delivery. Implications for inhalation system design. Am J Drug Deliv, 2005;3:117–32
   Google Scholar
• Qi L, Xu Z. In vivo antitumor activity of chitosan nanoparticles. Bioorg Med Chem Lett, 2006;16:4243–5
   PubMed Web of Science ®Google Scholar
• Qiang F, Shin H-J, Lee B-J, Han H-K. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. Int J Pharm, 2012;430:161–6
   PubMed Web of Science ®Google Scholar
• Tafaghodi M, Saluja V, Kersten GFA, Kraan H, Slütter B, Amorij J-P, Jiskoot W. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics. Vaccine, 2012;30:5341–8
   PubMed Web of Science ®Google Scholar
• Tahara K, Sakai T, Yamamoto H, Takeuchi H, Kawashima Y. Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery. Int J Pharm, 2008;354:210–16
   PubMed Web of Science ®Google Scholar
• Tahara K, Yamamoto H, Hirashima N, Kawashima Y. Chitosan-modified poly(d,l-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects. Eur J Pharm Biopharm, 2010;74:421–6
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Kuno Y, Sugimoto S, Takeuchi H, Kawashima Y. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Control Release, 2005;102:373–81
   PubMed Web of Science ®Google Scholar
• Yang M, Yamamoto H, Kurashima H, Takeuchi H, Yokoyama T, Tsujimoto H, Kawashima Y. Design and evaluation of poly(dl-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation. Eur J Pharm Sci, 2012;46(5):374–80
   PubMed Web of Science ®Google Scholar
• Yang R, Yang S-G, Shim W-S, Cui F, Cheng G, Kim I-W, Kim D-D, Chung S-J, Shim C-K. Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates. J Pharm Sci, 2009;98:970–84
   PubMed Web of Science ®Google Scholar
• Zeng P, Xu Y, Zeng C, Ren H, Peng M. Chitosan-modified poly(d,l-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Int J Pharm, 2011;415:259–66
   PubMed Web of Science ®Google Scholar
• Zheng CH, Gao JQ, Zhang YP, Liang WQ. A protein delivery system: Biodegradable alginate–chitosan–poly(lactic-co-glycolic acid) composite microspheres. Biochem Biophys Res Commun, 2004;323:1321–7
   PubMed Web of Science ®Google Scholar